PGFC
BMY.RT

Peapack-Gladstone Financial Corp’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Peapack-Gladstone Financial Corp’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-82,939
Closed -$57K – 606
2020
Q4 		$57K Sell
82,939
-22,966
-22% -$48.9K ﹤0.01% 431
2020
Q3 		$238K Sell
105,905
-871
-0.8% -$2.49K 0.01% 338
2020
Q2 		$382K Buy
106,776
+15,538
+17% +$56.1K 0.02% 298
2020
Q1 		$346K Sell
91,238
-182
-0.2% -$600 0.02% 290
2019
Q4 		$276K Buy
+91,420
New +$238K 0.01% 308

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Peapack-Gladstone Financial Corp's BMY.RT Position: Q1 2021 in Review

Peapack-Gladstone Financial Corp sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 82,939 shares — an estimated $57K sold.

Peapack-Gladstone Financial Corp first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $382K in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Peapack-Gladstone Financial Corp reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Peapack-Gladstone Financial Corp sold 82,939 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $57K.
  • Peapack-Gladstone Financial Corp first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Peapack-Gladstone Financial Corp's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $382K in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q1 2021, filed 14 May 2021.